Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 6,290.00
-40.00 (-0.63%)
Jul 1, 2026, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 35 billion as of June 30, 2026. Its market cap has decreased by -45.71% in one year.
Market Cap
35.00B
Enterprise Value
20.61B
Revenue
30.41B
Ranking
n/a
PE Ratio
6.62
Stock Price
6,290.00
Market Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 35.00B, a decrease of -87.83%. That is a compound annual growth rate of -67.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 35.00B | -35.74% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 62.17T |
| Celltrion | 36.46T |
| ALTEOGEN | 18.40T |
| Samsung Epis Holdings | 10.61T |
| Oncocross | 42.69B |
| MYUNGMOON Pharm co.,Ltd | 40.01B |
| HASS Corp. | 38.68B |
| BCWORLD PHARM. | 30.65B |